Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA1 | P30542 | 10/20 | 0.41 |
| ▸ | ADORA3 | P0DMS8 | 8/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 8/20 | 0.41 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.41 |
| ▸ | EGFR | P00533 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3171920 | 0.89 | ADORA1 (0.47) | ADORA1ADORA3ADORA2AADORA2BEGFR | |
| SCHEMBL3170808 | 0.89 | ANXA2 (0.52) | ALDH1A1ALOX15MAPK1HSD17B10 | |
| SCHEMBL3170804 | 0.89 | ANXA2 (0.52) | ALDH1A1ALOX15MAPK1HSD17B10 | |
| SCHEMBL3163144 | 0.88 | ADORA3 (0.46) | ADORA1ADORA3ADORA2AADORA2BEGFR | |
| SCHEMBL3163125 | 0.88 | NPC1 (0.47) | ADORA1ADORA3ADORA2AADORA2BALDH1A1 | |
| SCHEMBL3164709 | 0.88 | NPC1 (0.47) | ADORA1ADORA3ADORA2AADORA2BALDH1A1 | |
| SCHEMBL3161074 | 0.88 | ADORA2B (0.45) | ADORA1ADORA3ADORA2AADORA2BEGFR | |
| SCHEMBL3172495 | 0.87 | ADORA1 (0.40) | ADORA1ADORA3ADORA2AADORA2BEGFR | |
| SCHEMBL3163746 | 0.87 | ALDH1A1 (0.50) | ADORA1ADORA3ADORA2AADORA2BALDH1A1 | |
| SCHEMBL3162425 | 0.87 | EGFR (0.53) | EGFRALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1465631-B1 | PYRIMIDINE A2B SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE | OSI PHARM INC (US) | 2010-02-24 | — | — | EP | disclosed |